Wellness has reached critical mass — raising new questions about who shapes the category’s future.
Apothékary Adds New Funding
Apothékary raised $16M to expand retail distribution and accelerate product innovation.
- The herbal wellness brand’s functional tincture supplements provide Japanese medicine-inspired alternatives to coffee, alcohol, and pharma.
- This year, it’s targeting $40M in revenue, fueled by distribution at major retailers, TikTok Shop, and its own DTC business.
While brands built on paid social and DTC alone are struggling to raise capital, Apothékary is leveraging online acquisition and repeat purchase behavior to attract investors with confidence.
The playbook for wellness brands is changing. Winning online still matters, but building a durable omnichannel business matters more.
Wellness Culture Expands Beyond Optimization
Wellness consumers are seeking experiences beyond optimization, swapping wearables, ice baths, and recovery clubs for new venues.
Listening bars, tea houses, reading clubs, and phone-free gatherings are creating space for conversation, creativity, and community without turning health into another performance metric.
As the category expands, brands have an opportunity to build for people who value presence, taste, and connection as much as performance.
Peptides Reach a Turning Point
The FDA announced a new advisory committee that will help determine whether several peptides can be compounded by pharmacies, setting up one of the biggest regulatory debates in longevity medicine.
- The panel will consider compounds including BPC-157, TB-500, MOTS-c, and others that have gained traction despite limited clinical evidence.
- Several newly appointed advisers have ties to businesses that prescribe peptides, raising questions about potential conflicts of interest.
As peptides move from gray-market experimentation toward regulated healthcare, the July meeting will shape what access looks like over the next decade.
